{"slug":"bispecific","tag":"bispecific","variants":["bispecific"],"description":"No description yet","count":6,"kinds":{"person":6},"related":[{"slug":"lymphoma","tag":"lymphoma","shared":2},{"slug":"myeloma","tag":"myeloma","shared":2},{"slug":"australia","tag":"australia","shared":1},{"slug":"china","tag":"china","shared":1},{"slug":"gprc5d","tag":"gprc5d","shared":1},{"slug":"lung","tag":"lung","shared":1},{"slug":"lysa","tag":"lysa","shared":1},{"slug":"trialist","tag":"trialist","shared":1},{"slug":"uk","tag":"uk","shared":1},{"slug":"uveal-melanoma","tag":"uveal-melanoma","shared":1}],"records":[{"id":"qing-zhou","kind":"person","name":"Qing Zhou","route":"/people/qing-zhou/","tldr":"Chinese thoracic oncologist behind HARMONi-2, where the PD-1/VEGF bispecific ivonescimab beat pembrolizumab head to head."},{"id":"paul-nathan","kind":"person","name":"Paul Nathan","route":"/people/paul-nathan/","tldr":"Led the tebentafusp trial, the first treatment ever to extend survival in metastatic uveal melanoma."},{"id":"michael-dickinson","kind":"person","name":"Michael Dickinson","route":"/people/michael-dickinson/","tldr":"Led the pivotal glofitamab trial, establishing off-the-shelf bispecific antibodies for relapsed large B-cell lymphoma."},{"id":"catherine-thieblemont","kind":"person","name":"Catherine Thieblemont","route":"/people/catherine-thieblemont/","tldr":"Led EPCORE NHL-1, the trial that established the subcutaneous bispecific epcoritamab for relapsed large B-cell lymphoma."},{"id":"philippe-moreau","kind":"person","name":"Philippe Moreau","route":"/people/philippe-moreau/","tldr":"Led MajesTEC-1 and CASSIOPEIA, bringing the first bispecific antibody and daratumumab quadruplets to myeloma."},{"id":"ajai-chari","kind":"person","name":"Ajai Chari","route":"/people/ajai-chari/","tldr":"Led the pivotal talquetamab trial, establishing GPRC5D as the second bispecific target in myeloma."}]}